The Latest Breaking News from Centessa Pharmaceuticals

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8B in Sleep Drug Mega-Deal, CNTA Stock Soaring 45%

Shares of Centessa Pharmaceuticals plc skyrocketed more than 44% Tuesday after the clinical-stage biotech announced it would be acquired by pharmaceutical giant Eli Lilly and Co. in a deal valued at up to $7.8 billion, giving Lilly a promising pipeline of experimental treatments for sleep-wake disorders.

International Business Times · Mar 31

4 Analysts Have This to Say About Centessa Pharmaceuticals

Analysts have provided the following ratings for Centessa Pharmaceuticals (NASDAQ:CNTA) within the last quarter:

Benzinga · Jun 17, 2022